Does timing of targeted therapy for metastatic renal cell carcinoma impact treatment toxicity and surgical complications? A comparison of primary and adjuvant approaches

Nishant Patel, Jason Woo, Michael A. Liss, Kerrin L. Palazzi, J. Michael Randall, Reza Mehrazin, Ramzi Jabaji, Hossein S. Mirheydar, Kyle Gillis, Hak J. Lee, Anthony L. Patterson, Christopher J. Kane, Frederick Millard, Ithaar H. Derweesh

Research output: Contribution to journalArticlepeer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Does timing of targeted therapy for metastatic renal cell carcinoma impact treatment toxicity and surgical complications? A comparison of primary and adjuvant approaches'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology